Incidence and mortality of mucous membrane pemphigoid in France

View at publisher
Authors: Alexis Lefebvre, André Gillibert, Emmanuelle Tancrède‐Bohin, Louise Loridon, C. Lepelletier, F. Lombart, Anne Pham-Ledard, C. Abasq, Saskia Oro, Sophie Duvert-Lehembre, P. Modiano, C. Becquart
+17 more Christophe Bédane, Gaëlle Quéreux, Catherine Picard-Dahan, Nicolas Dupin, M. Viguier, Céline Muller, D Jullien, Marine Chastagner, G. Jeudy, Marie-Aleth Richard, C. Morice, N. Litrowski, S. Debarbieux, Julien Grosjean, Vivien Hébert, Pascal Joly, Billal Tedbirt
Cited by: 3
References: 26

Abstract

BACKGROUND: Data on the incidence and mortality rates of mucous membrane pemphigoid (MMP) are limited and outdated. OBJECTIVES: To estimate the incidence and standardized mortality ratios (SMR) of MMP and identify prognostic factors for mortality. METHODS: We screened patients with MMP diagnosed in 20 dermatology departments in France between 2000 and 2021, using 3 national databases. The incidence rate was calculated based on the number of inhabitants in the corresponding administrative regions and patients' vital status was obtained from the French Institut national de la statistique et des études économiques (INSEE) death register. RESULTS: A total of 663 patients (376 women, 287 men) with a mean (SD) age of 70.57 (13.58) years was included. Annualized incidence rates progressively increased over the years, from 1.38 cases per million inhabitants per year in 2012 to a peak of 3.86 in 2019. The highest annualized incidence rate was observed in patients aged between 80 and 85 years [9.91 cases per million inhabitants per year; 95% confidence interval (CI) 6.43-15.28]. The 1-, 3- and 5-year SMRs were 1.00 (95% CI 0.73-1.33), 1.05 (95% CI 0.85-1.26) and 1.01 (95% CI 0.85-1.18), respectively. A higher SMR was observed in patients with ear, nose and throat (ENT) involvement (SMR 1.26, 95% CI 1.00-1.55). Predictors of mortality included age [hazard ratio (HR) 3.65 for ages 75-85 years vs. < 65 years (95% CI 1.67-7.99; P = 0.001) and 11.94 for ages > 85 years (95% CI 5.40-26.41; P < 0.001)], cancer (HR 2.66, 95% CI 1.75-4.06; P < 0.001) and diabetes (HR 1.80, 95% CI 1.17-2.77; P = 0.008). Patients with ocular-only involvement (HR 1.96, 95% CI 0.95-4.05; P = 0.07) and ENT involvement (HR 1.63, 95% CI 0.96-2.78; P = 0.07) had a trend towards a higher risk of mortality compared with oral forms of MMP. CONCLUSIONS: The incidence rate of MMP in France has more than doubled over the last decade. Ocular-only and ENT involvement are associated with a higher risk of mortality.

Fields of Study & Subjects

Autoimmune Bullous Skin Diseases Skin Diseases and Diabetes Dermatology and Skin Diseases

Publication details

Journal / source
British Journal of Dermatology
Publisher
Oxford University Press (OUP)
Volume
195
Issue
3
Pages
441–450
Publication date
9 May 2026
Language
EN